Iefke Drion1, Loes R Pameijer2, Peter R van Dijk2, Klaas H Groenier3, Nanne Kleefstra4, Henk J G Bilo5. 1. Diabetes Centre, Isala Clinics, Zwolle, Netherlands i.drion@umcg.nl. 2. Diabetes Centre, Isala Clinics, Zwolle, Netherlands. 3. Diabetes Centre, Isala Clinics, Zwolle, Netherlands Department of General Practice, University of Groningen, UMCG, Groningen, Netherlands. 4. Diabetes Centre, Isala Clinics, Zwolle, Netherlands Department of Internal Medicine, University of Groningen, UMCG, Groningen, Netherlands Medical Research Group, Langerhans, Zwolle, Netherlands. 5. Diabetes Centre, Isala Clinics, Zwolle, Netherlands Department of Internal Medicine, University of Groningen, UMCG, Groningen, Netherlands Department of Internal Medicine, Isala Clinics, Zwolle, Netherlands.
Abstract
BACKGROUND: The combination of an increasing prevalence of diabetes mellitus and more people having access to smartphones creates opportunities for patient care. This study aims to investigate whether the use of the Diabetes Under Control (DBEES) mobile phone application, a digital diabetes diary, results in a change in quality of life for patients with type 1 diabetes mellitus (T1DM) compared with the standard paper diary. METHODS: In this randomized controlled open-label trial, 63 patients with T1DM having access to a smartphone were assigned to the intervention group using the DBEES application (n = 31) or the control group using the standard paper diary (n = 32). Primary outcome was the change in quality of life, as measured by the RAND-36 questionnaire, between both groups. Secondary outcomes included diabetes-related distress (PAID), HbA1c, frequency of self-monitoring blood glucose, and the usability of the diabetes application (SUS). RESULTS:Patients had a median age (IQR) of 33 (21) years, diabetes duration of 17 (16) years, and an HbA1c of 62 ± 16 mmol/mol. No significant differences in the QOL, using the RAND-36, within and between both groups were observed after 3 months. Glycemic control, diabetes-related emotional distress, and frequency of self-monitoring of blood glucose remained within and between groups. Users reviewed the usability of DBEES with a 72 ± 20, on a range of 0-100. CONCLUSIONS: The use of the DBEES application in the management of patients with T1DM for 3 months yields no alterations in quality of life compared to the standard paper diary.
RCT Entities:
BACKGROUND: The combination of an increasing prevalence of diabetes mellitus and more people having access to smartphones creates opportunities for patient care. This study aims to investigate whether the use of the Diabetes Under Control (DBEES) mobile phone application, a digital diabetes diary, results in a change in quality of life for patients with type 1 diabetes mellitus (T1DM) compared with the standard paper diary. METHODS: In this randomized controlled open-label trial, 63 patients with T1DM having access to a smartphone were assigned to the intervention group using the DBEES application (n = 31) or the control group using the standard paper diary (n = 32). Primary outcome was the change in quality of life, as measured by the RAND-36 questionnaire, between both groups. Secondary outcomes included diabetes-related distress (PAID), HbA1c, frequency of self-monitoring blood glucose, and the usability of the diabetes application (SUS). RESULTS:Patients had a median age (IQR) of 33 (21) years, diabetes duration of 17 (16) years, and an HbA1c of 62 ± 16 mmol/mol. No significant differences in the QOL, using the RAND-36, within and between both groups were observed after 3 months. Glycemic control, diabetes-related emotional distress, and frequency of self-monitoring of blood glucose remained within and between groups. Users reviewed the usability of DBEES with a 72 ± 20, on a range of 0-100. CONCLUSIONS: The use of the DBEES application in the management of patients with T1DM for 3 months yields no alterations in quality of life compared to the standard paper diary.
Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245
Authors: W H Polonsky; B J Anderson; P A Lohrer; G Welch; A M Jacobson; J E Aponte; C E Schwartz Journal: Diabetes Care Date: 1995-06 Impact factor: 19.112
Authors: Maria C E Rossi; Antonio Nicolucci; Fabio Pellegrini; Daniela Bruttomesso; Paolo Di Bartolo; Giuseppe Marelli; Michela Dal Pos; Marianna Galetta; David Horwitz; Giacomo Vespasiani Journal: Diabetes Technol Ther Date: 2009-01 Impact factor: 6.118
Authors: Nanne Kleefstra; Gijs W D Landman; Sebastiaan T Houweling; Lielith J Ubink-Veltmaat; Susan J J Logtenberg; Betty Meyboom-de Jong; James C Coyne; Klaas H Groenier; Henk J G Bilo Journal: Diabetes Care Date: 2008-03-04 Impact factor: 19.112
Authors: Sara Belle Donevant; Robin Dawson Estrada; Joan Marie Culley; Brian Habing; Swann Arp Adams Journal: J Am Med Inform Assoc Date: 2018-10-01 Impact factor: 4.497
Authors: Binay Kumar Pramanik; J Jebashini Angelin; Vineeth John Mathai; Sarah Mathai; Sophy Korula; Anna Simon Journal: Indian J Pediatr Date: 2019-07-29 Impact factor: 1.967
Authors: Stephanie Veazie; Kara Winchell; Jennifer Gilbert; Robin Paynter; Ilya Ivlev; Karen B Eden; Kerri Nussbaum; Nicole Weiskopf; Jeanne-Marie Guise; Mark Helfand Journal: J Gen Intern Med Date: 2018-05-08 Impact factor: 5.128